Pfizer is looking for US approval of a booster dose of its two-shot COVID-19 vaccine. The drugmaker claimed Wednesday that it's started off the appliance course of action for a third dose of its vaccine for individuals ages sixteen and more mature. The corporate claimed it is going to comprehensive http://web.es.nccu.edu.tw/class/netlink/hits.php?id=269&url=https://getlisting.org/